Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Q3 venture financing rebounds

This article was originally published in Scrip

Executive Summary

Venture capital investment into biotech drug discovery and development companies in the third quarter returned to historical levels following a strong September. The total amount of money put to work in the global sector during Q3 was about $1.46 billion. In the past five years, with the exception of 2009, biotech companies raised between $1.4 billion and $1.5 billion over the summer months. In 2009, the sector barely raised $1.1 billion.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts